Answers are grounded in this paper and cite their sources.
Objective This systematic review and meta-analysis evaluated the association of a body shape index (ABSI) and body roundness index (BRI) in women with polycystic ovary syndrome (PCOS), also known as polyendocrine metabolic ovary syndrome (PMOS).Methods This study was registered at PROSPERO [CRD420251177545] and followed the PRISMA Guidelines. We searched evidence in PubMed, Scopus, Web of Science, Embase, and SciELO databases. Two case–control and seven cross-sectional studies reported ABSI and BRI results in PMOS patients and women without the syndrome.Results Systematic review and meta-analysis of ABSI (eight studies, 3193 participants) association with PMOS (SMD = 0.45, 95%CI = 0.07, 0.83; I 2 = 90.5%, τ2 = 0.18) and body mass index (BMI) (MD = 3.76, 95%CI = 1.61, 5.91 kg/m2; I 2 = 93.8%, τ2 = 5.84). In five studies (840 participants), BRI levels were higher in PMOS patients than in the control group (SMD = 1.09, 95%CI = 0.53–1.66) 95%CI = 0.53–1.66; I 2 = 85.9%; τ2 = 0.17), and BMI MD = 4.31 kg/m2, 95%CI = 1.98, 6.65; I 2 = 83.9%, τ2 = 2.87). Subgroup analyzes by geographic region showed no significant differences in ABSI and BRI estimates between European and Asian. The BRI finding remained statistically significant in all leave-one-out analyzes, whereas the statistical significance of the ABSI finding was sensitive to individual study exclusion.Conclusion PMOS patients have enhanced ABSI and BRI levels compared to women without the syndrome. Further high-quality studies from other world regions are needed to evaluate heterogeneity at different PMOS clinical stages.
No takes yet. Share an insight, caveat, or question.
Pérez-López et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: